Shield Therapeutics assumes full U.S. control of ACCRUFeR
Shield Therapeutics assumes full control of ACCRUFeR in the US.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Shield Therapeutics assumes full control of ACCRUFeR in the US.